Medullary Thyroid Carcinoma Latest Advances

Update of pathology in medullary thyroid carcinoma

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: October 10, 2025

Medullary thyroid carcinoma exclusively associated with a homozygous RET V778I pathogenic variant: a case report with review of literature.

Journal: Endocrine journal

Published: October 05, 2025

Letter to the Editor: Revisiting a "Revised Perspective on the American Joint Committee on Cancer's Staging System for Medullary Thyroid Cancer".

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: September 10, 2025

Authors' Reply to the Letter to the Editor by Foote et al: Revisiting a "Revised Perspective on the American Joint Committee on Cancer's Staging System for Medullary Thyroid Cancer".

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: September 10, 2025

ASO Visual Abstract: Sex-Based Differences in Medullary Thyroid Cancer Survival: A Matched Analysis of 4602 Patients.

Journal: Annals of surgical oncology

Published: September 05, 2025

Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid Carcinoma.

Journal: Thyroid : official journal of the American Thyroid Association

Published: September 02, 2025

Predictors of Distant Metastasis in Patients with Medullary Thyroid Carcinoma.

Journal: Cancers

Published: August 22, 2025

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.

Journal: Thyroid : official journal of the American Thyroid Association

Published: August 19, 2025

Activating RET Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer.

Journal: bioRxiv : the preprint server for biology

Published: August 12, 2025

Value of 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) in the Detection of Recurrence in Medullary Thyroid Carcinoma With Negative Conventional Imaging: A Case Report.

Journal: Cureus

Published: August 04, 2025

Medullary Thyroid Cancer: Our Current Understanding of Optimum Treatment.

Journal: Endocrinology and metabolism clinics of North America

Published: July 27, 2025

Quantitative Ultrasound-Based Precision Diagnosis of Papillary, Follicular, and Medullary Thyroid Carcinomas Using Morphological, Structural, and Textural Features.

Journal: Cancers

Published: July 27, 2025

Filters

Update of pathology in medullary thyroid carcinoma

Update of pathology in medullary thyroid carcinoma

Medullary thyroid carcinoma exclusively associated with a homozygous RET V778I pathogenic variant: a case report with review of literature.

Medullary thyroid carcinoma exclusively associated with a homozygous RET V778I pathogenic variant: a case report with review of literature.

Letter to the Editor: Revisiting a "Revised Perspective on the American Joint Committee on Cancer's Staging System for Medullary Thyroid Cancer".

Letter to the Editor: Revisiting a "Revised Perspective on the American Joint Committee on Cancer's Staging System for Medullary Thyroid Cancer".

Authors' Reply to the Letter to the Editor by Foote et al: Revisiting a "Revised Perspective on the American Joint Committee on Cancer's Staging System for Medullary Thyroid Cancer".

Authors' Reply to the Letter to the Editor by Foote et al: Revisiting a "Revised Perspective on the American Joint Committee on Cancer's Staging System for Medullary Thyroid Cancer".

ASO Visual Abstract: Sex-Based Differences in Medullary Thyroid Cancer Survival: A Matched Analysis of 4602 Patients.

ASO Visual Abstract: Sex-Based Differences in Medullary Thyroid Cancer Survival: A Matched Analysis of 4602 Patients.

Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid Carcinoma.

Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid Carcinoma.

Predictors of Distant Metastasis in Patients with Medullary Thyroid Carcinoma.

Predictors of Distant Metastasis in Patients with Medullary Thyroid Carcinoma.

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.

Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.

Activating RET Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer.

Activating RET Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer.

Value of 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) in the Detection of Recurrence in Medullary Thyroid Carcinoma With Negative Conventional Imaging: A Case Report.

Value of 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) in the Detection of Recurrence in Medullary Thyroid Carcinoma With Negative Conventional Imaging: A Case Report.

Medullary Thyroid Cancer: Our Current Understanding of Optimum Treatment.

Medullary Thyroid Cancer: Our Current Understanding of Optimum Treatment.

Quantitative Ultrasound-Based Precision Diagnosis of Papillary, Follicular, and Medullary Thyroid Carcinomas Using Morphological, Structural, and Textural Features.

Quantitative Ultrasound-Based Precision Diagnosis of Papillary, Follicular, and Medullary Thyroid Carcinomas Using Morphological, Structural, and Textural Features.